Insights beyond genes
Complement genomic data with protein measurements reflecting dynamic cancer processes such as immune activity, inflammation, and beyond.
Genomics provides vital information on DNA alterations driving cancer, but proteomics offers a direct window into active biological processes. By combining the insights from both approaches, you can build more complete biomarker strategies for translational and clinical oncology research.

Genomics only
Genomics + proteomics
Allows dynamic readouts of immune response, inflammation, and the tumor microenvironment
Enables measurement of circulating proteins linked to inflammation, immune modulation, and treatment-related toxicity
Identifies potential signatures for prognosis and prediction of response, enriching biomarker discovery and multimodal models
Can guide potential strategies for improved risk stratification and early detection
While genomic data can identify mutations and other molecular alterations that predict probable cancer outcomes, genomics alone fails to capture the true dynamic nature of this disease. Proteomics adds functional insights to oncology research, but adoption has been historically limited by concerns around workflow complexity, reproducibility, and analytical performance.
You need tools that support:


Deepen your understanding of proteomics in oncology by exploring our curated resources.
Explore further reading to understand the potential of proteomics in cancer research.
Access key papers, white papers, and technical notes supporting Olink proteomics in oncology research.
| Documents | Type | File |
|---|---|---|
| Performance Comparison of Assays Usable for FDA Project Optimus | White paper | |
| Proteomics accelerates translational oncology research | Flyer | |
| How proteomics enriches early cancer detection | Technical note | |
| Advancing biomarker discovery in ovarian cancer with Olink® Explore HT | Case study | Download PDF |
| Olink® Reveal Chronic Lymphocytic Leukemia Case Study | Case study | |
| Cytokine changes in the aged tumor microenvironment in a mouse model | Case study | Download PDF |
| Insights into immuno-oncology research | Flyer | |
| Insights into Th cytokine profiling in disease research | Flyer | |
| Insights into the predictive value of blood IFN signature in cancer | Flyer |
Measure 5,400+ proteins with proven specificity to gain an understanding of disease at the protein level.
5,400+ With proven specificity
2 µL Plasma, serum & more
Accessible NGS-based proteomics for every lab. Unplugged from complexity, powered by insights
>1,000 Powerful. Simple. Accessible
4 µL Plasma, serum & more
Target specific disease areas or key biological processes with multiplex immunoassay panels.
92 11 targeted panels
1 µL Plasma, serum & more
Extensively validated and carefully selected biomarkers for a comprehensive view of immune and neurodegeneration processes.
up to 45 3 panels
1 µL Plasma, serum & more
Whether you are looking for full-service sample analysis, support from a Certified Service Provider, or want to run the assays in your own lab, you can access Olink solutions in a way that fits your study designs and infrastructure needs.